|
|||||
|
|
Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers |
|
| Authors: | H. J. L. Heerspink E. Johnsson I. Gause‐Nilsson V. A. Cain C. D. Sjöström |
| Affiliation: | 1. University of Groningen, University Medical Center, Groningen, The Netherlands;2. AstraZeneca, Gothenburg, M?lndal, Sweden;3. AstraZeneca, Wilmington, DE, USA |
| Abstract: | |
| Keywords: | albuminuria dapagliflozin diabetes hypertension sodium glucose cotransporter‐2 |